The central nervous system drugs
market includes medications that are used in the treatment of diseases
affecting the brain or spinal cord. The central nervous system (CNS) integrates
sensory information and instructs the body to respond accordingly. The spinal
cord is a channel for signals between the brain and the rest of the body.
Central nervous system (CNS) disorder is a condition in which the brain and
spinal cord’s ability to function is affected, hence affecting the body. The
market for CNS disorder drugs comprises of drugs that work in different ways
depending on the type of disease by suppressing or boosting the brain
activities. Top selling neurological drugs in 2016 include Copaxone, Lyrica,
and Tecfidera.
Read more:
The global central nervous system
drugs market has been growing in the past years with a CAGR of almost 5.2%.
TBRC’s latest report show the historic and future trends in the market for each
year with sourced reasons to support the growth claims.
The report also shows the global central
nervous system drugs market to grow at a higher CAGR by 2021 as compared to
2017, along with geographies best suited for investments with highest return
rate.
Download sample
report at:
Regenerative therapies for the
treatment of central nervous system diseases is one of the emerging trends in
the global central nervous system drugs market. CNS diseases such as
Alzheimer’s, Parkinson’s disease, spinal cord injury and optic neuropathies are
complex disorders and cannot be completely cured by current therapeutic
strategies, hence facilitating the need for regenerative therapies.
Regenerative therapies are medications that replace, engineer or regrow damaged
cells to treat a particular disease. These therapies help in the healing
process by regenerating human cells, tissues, and organs. Major regenerative
therapies include transplantation by embryonic stem cells, usage of matrix such
as fibrin, collagen, and hyaluronic acid.
Request for discount: https://www.thebusinessresearchcompany.com/sample.aspx?id=279&type=discount
Companies included in the report
are Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson,
Pfizer Inc.,
Novartis AG, Shire Plc., UCB S.A., Eli Lilly And Company, Sanofi S.A., and Daiichi
Sankyo Company, Limited.
About The Business
Research Company:
The Business Research Company is a Business Intelligence
Company which excels in company, market and consumer research. It has offices
in the UK, the US and India and a network of trained researchers in 15
countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment